AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item:
Title: Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain
Authors: Staats Pires A
Heng B
Tan VX
Latini A
Russo M 
Santarelli DM
Bailey D
Wynne K
O'Brien JA
Guillemin GJ
Austin PJ
Keywords: kynurenine
neuropathic pain
pro-inflammatory cytokines
type 1 diabetes
Issue Date: 21-Aug-2020
Source: 2020 Aug 21:14:890.
Abstract: Neuropathic pain is a common complication of diabetes with high morbidity and poor treatment outcomes. Accumulating evidence suggests the immune system is involved in the development of diabetic neuropathy, whilst neuro-immune interactions involving the kynurenine (KYN) and tetrahydrobiopterin (BH4) pathways have been linked to neuropathic pain pre-clinically and in several chronic pain conditions. Here, using a multiplex assay, we quantified serum levels of 14 cytokines in 21 participants with type 1 diabetes mellitus, 13 of which were classified as having neuropathic pain. In addition, using high performance liquid chromatography and gas chromatography-mass spectrometry, all major KYN and BH4 pathway metabolites were quantified in serum from the same cohort. Our results show increases in GM-CSF and IL-8, suggesting immune cell involvement. We demonstrated increases in two inflammatory biomarkers: neopterin and the KYN/TRP ratio, a marker of indoleamine 2,3-dioxygenase activity. Moreover, the KYN/TRP ratio positively correlated with pain intensity. Total kynurenine aminotransferase activity was also higher in the diabetic neuropathic pain group, indicating there may be increased production of the KYN metabolite, xanthurenic acid. Overall, this study supports the idea that inflammatory activation of the KYN and BH4 pathways occurs due to elevated inflammatory cytokines, which might be involved in the pathogenesis of neuropathic pain in type 1 diabetes mellitus. Further studies should be carried out to investigate the role of KYN and BH4 pathways, which could strengthen the case for therapeutically targeting them in neuropathic pain conditions.
ISSN: 1662-453X
Appears in Collections:Scholarly and Clinical

Files in This Item:
File Description SizeFormat 
Kynurenine Tetrahydrobiopterin and Cytokine Inflammatory Biomarkers in Individuals Affected by DNP.pdf
  Restricted Access
1.83 MBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

checked on May 23, 2024


checked on May 23, 2024

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.